Costimulatory pathway targets for autoimmune and inflammatory conditions: clinical successes, failures, and hope for the future

  • Expert Opin Investig Drugs. 2019 Feb;28(2):99-106. doi: 10.1080/13543784.2019.1557146.
Pamela Spicer  1 ,  Laura Runkel  1
Affiliations
  • 1. a Informa Pharma Intelligence , New York , NY , USA.
PMID: 30661473 DOI: 10.1080/13543784.2019.1557146
Keywords
Autoimmune diseases; CD28; CD40; ICOS; OX40; costimulatory signals.
Products